Israel Englander’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Israel Englander’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,000	Closed	-$234K	–	7410
2021 Q1	$234K	Buy	+10,000	New	+$303K	﹤0.01%	5405
2020 Q3	–	Sell	-41,600	Closed	-$1.25M	–	4993
2020 Q2	$1.25M	Hold	41,600	–	–	﹤0.01%	2855
2020 Q1	$1.31M	Buy	41,600 +31,600	+316%	+$1.1M	﹤0.01%	2295
2019 Q4	$471K	Buy	+10,000	New	+$289K	﹤0.01%	3421

Israel Englander's CNST Position: Q3 2021 in Review

Israel Englander sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 852,040 shares — an estimated $28.8M sold.

Israel Englander first reported a position in CNST in Q3 2018 and held it in 7 quarters. The position peaked at $28.8M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Israel Englander reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Israel Englander sold 852,040 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $28.8M.
Israel Englander first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 7 quarters.
Israel Englander's Constellation Pharmaceuticals, Inc. position peaked at $28.8M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.